Agilent Announces Cash Dividend of 25.5 Cents Per Share

Audio By Carbonatix

SANTA CLARA, Calif.--(BUSINESS WIRE)--Nov 19, 2025--

Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on Jan. 28, 2026, to all shareholders of record as of the close of business on Jan. 6, 2026.

The timing and amounts of future dividends are subject to the determination and approval by Agilent’s board of directors.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide. Information about Agilent is available atwww.agilent.com. To receive the latest Agilent news, subscribe to ourNewsroom. Follow Agilent onLinkedInandFacebook.

Forward-Looking Statements

This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding the company’s dividend program and future payment obligations. These forward-looking statements involve risks and uncertainties that could cause Agilent’s results to differ materially from management’s current expectations. Such risks and uncertainties are detailed in Agilent’s filings with the Securities and Exchange Commission, including our quarterly report on Form 10-Q for the quarter ended July 31, 2025. Forward-looking statements are based on the beliefs and assumptions of Agilent’s management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251118685521/en/

CONTACT: INVESTOR CONTACT:

Tejas Savant

+1 917-574-4018

[email protected] CONTACT:

Kate Coyle

+1 302-633-7490

[email protected]

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH HEALTH TECHNOLOGY GENERAL HEALTH RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Agilent Technologies Inc.

Copyright Business Wire 2025.

PUB: 11/19/2025 04:15 PM/DISC: 11/19/2025 04:15 PM

http://www.businesswire.com/news/home/20251118685521/en